Primary outcome (pain visual analog scale)
As shown in Fig. Non-inferiority of intraarticular Triamcinolone 10 mg versus Triamcinolone 40 mg for the treatment of symptomatic knee osteoarthritisBoth 10 and 40 mg TA significantly improved pVAS at week 12 compared to baseline. The mean differences (95%CI) in pVAS scores at week 12 and baseline were -2.2 (-2.3, -2.1) and -1.4 (-1.5, -1.3) in 10 mg and 40 mg groups, respectively and the 